Sturaro's Match-Issued Signed Shirt, Genoa-Sampdoria 2019
Take home this red and blue Genoa CFC home shirt issued to Stefano Sturaro for the 119th "Derby della Lanterna" event.
For the match against Genoa, played on Saturday December 14 at the Luigi Ferraris Stadium in Genoa, U.C. Sampdoria took to the field in shirts featuring a special patch dedicated to Gaslini Hospital, the largest pediatric hospital in northern Italy, with its 22 buildings and over 2 thousand employees including medical and university staff, researchers, specialists and nurses.
The Serie A football teams played to support research on the treatment of rare genetic diseases, this season for the 30th Telethon promoted by the foundation.
Sturaro has signed the shirt on the back making it a truly unique collector's item.
- Red and blue short-sleeved home shirt
- Issued to Stefano Sturaro
- Genoa CFC emblem on chest
- Sponsored by Kappa
- Serie A TIM patch on right sleeve
- "Insieme per il Gaslini" patch on left sleeve
- Name and number in smooth plastic lettering
- #27, size XL
This item was supplied to the squad for a match, was made available to the players on matchday and differs from the shirts found on general sale.
Since 1990, we have been investing in the best research to find cures for rare genetic diseases. Because these diseases are so rare, often times there is no research being done on them, never mind therapeutic options or a cure.
We want to change this state of affairs because we believe that every person is worth fighting for.
We focus on transforming the results of excellent scientific research projects, selected and supported over time, into accessible treatments.
Finding a cure is not the final destination but a new starting point. We have to make every possible effort to guarantee that successful forms of treatment discovered through the research funded by Telethon are then made available to all patients.
For this reason we also work to develop partnerships with public health care institutions and pharmaceutical companies, so that the results of our research will translate to treatment and medicine accessible to all patients worldwide.